serw-MX  [xml]  
 


    
 DeCS Categories

C05 Musculoskeletal Diseases .
C05.651 Muscular Diseases .
C05.651.460 Mitochondrial Myopathies .
C05.651.460.700 Ophthalmoplegia, Chronic Progressive External .
C10 Nervous System Diseases .
C10.292 Cranial Nerve Diseases .
C10.292.562 Ocular Motility Disorders .
C10.292.562.750 Ophthalmoplegia .
C10.292.562.750.250 Ophthalmoplegia, Chronic Progressive External .
C10.597 Neurologic Manifestations .
C10.597.622 Paralysis .
C10.597.622.447 Ophthalmoplegia .
C10.597.622.447.511 Ophthalmoplegia, Chronic Progressive External .
C10.668 Neuromuscular Diseases .
C10.668.491 Muscular Diseases .
C10.668.491.500 Mitochondrial Myopathies .
C10.668.491.500.700 Ophthalmoplegia, Chronic Progressive External .
C11 Eye Diseases .
C11.590 Ocular Motility Disorders .
C11.590.472 Ophthalmoplegia .
C11.590.472.250 Ophthalmoplegia, Chronic Progressive External .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.660 Mitochondrial Diseases .
C18.452.660.560 Mitochondrial Myopathies .
C18.452.660.560.700 Ophthalmoplegia, Chronic Progressive External .
C23 Pathological Conditions, Signs and Symptoms .
C23.888 Signs and Symptoms .
C23.888.592 Neurologic Manifestations .
C23.888.592.636 Paralysis .
C23.888.592.636.447 Ophthalmoplegia .
C23.888.592.636.447.511 Ophthalmoplegia, Chronic Progressive External .
D02 Organic Chemicals .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.847 Polycyclic Aromatic Hydrocarbons .
D02.455.426.559.847.562 Naphthacenes .
D02.455.426.559.847.562.050 Anthracyclines .
D02.455.426.559.847.562.050.200 Daunorubicin .
D02.455.426.559.847.562.050.200.650 Nogalamycin .
D02.455.426.559.847.562.050.200.650.500 Menogaril .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.606 Piperazines .
D03.383.606.385 Diketopiperazines .
D03.383.606.385.500 Razoxane .
D03.383.606.385.500.500 Dexrazoxane .
D04 Polycyclic Compounds .
D04.615 Polycyclic Aromatic Hydrocarbons .
D04.615.562 Naphthacenes .
D04.615.562.050 Anthracyclines .
D04.615.562.050.200 Daunorubicin .
D04.615.562.050.200.650 Nogalamycin .
D04.615.562.050.200.650.500 Menogaril .
D09 Carbohydrates .
D09.408 Glycosides .
D09.408.051 Aminoglycosides .
D09.408.051.059 Anthracyclines .
D09.408.051.059.200 Daunorubicin .
D09.408.051.059.200.650 Nogalamycin .
D09.408.051.059.200.650.500 Menogaril .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.276 Intercellular Signaling Peptides and Proteins .
D12.644.276.374 Cytokines .
D12.644.276.374.465 Interleukins .
D12.644.276.374.465.511 Interleukin-11 .
D12.776 Proteins .
D12.776.467 Intercellular Signaling Peptides and Proteins .
D12.776.467.374 Cytokines .
D12.776.467.374.465 Interleukins .
D12.776.467.374.465.511 Interleukin-11 .
D23 Biological Factors .
D23.529 Intercellular Signaling Peptides and Proteins .
D23.529.374 Cytokines .
D23.529.374.465 Interleukins .
D23.529.374.465.511 Interleukin-11 .
E01 Diagnosis .
E01.370 Diagnostic Techniques and Procedures .
E01.370.350 Diagnostic Imaging .
E01.370.350.515 Microscopy .
E01.370.350.515.402 Microscopy, Electron .
E01.370.350.515.402.580 Microscopy, Electron, Transmission .
E01.370.350.515.402.580.480 Microscopy, Electron, Scanning Transmission .
E05 Investigative Techniques .
E05.595 Microscopy .
E05.595.402 Microscopy, Electron .
E05.595.402.580 Microscopy, Electron, Transmission .
E05.595.402.580.480 Microscopy, Electron, Scanning Transmission .
V01 Publication Components .
V01.255 Electronic Supplementary Materials .
V01.255.500 Video-Audio Media .
V01.255.500.625 Interactive Tutorial .
V02 Publication Formats .
V02.600 Journal Article .
V02.600.500 Review .
V02.912 Review .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Menogaril .
7-O-Methylnogarol .
7-OMEN .
7-con-O-Methylnogarol .
Menogaril, (11 beta)-Isomer .
Menogaril, (13 beta)-Isomer .
Menogaril, (5 alpha)-Isomer .
Menogaril, (5 alpha,11 beta)-Isomer .
Menogarol .
NSC-269148 .
TUT-7 .
Tomosar .
NSC 269148 .
NSC269148 .
TUT 7 .
TUT7 18773 .
NSC-269148 .
A semisynthetic anthracycline with the amino sugar on the D ring. It displays broad-spectrum antineoplastic activity against a variety of tumors. .
1.00
0104
 
Dexrazoxane .
ADR-529 .
Cardioxan .
Cardioxane .
Dexrazoxane Hydrochloride .
ICRF-187 .
NSC-169780 .
Razoxane, (S)-Isomer .
Razoxane, (S)-Isomer, Hydrochloride .
Zinecard .
ADR 529 .
ADR529 .
Hydrochloride, Dexrazoxane .
ICRF 187 .
ICRF187 .
NSC 169780 .
NSC169780 .
The (+)-enantiomorph of razoxane. .
0.39
251
 
Microscopy, Electron, Scanning Transmission .
Electron Microscopy, Scanning Transmission .
Scanning Transmission Electron Microscopy .
STEM 18769 .
A type of TRANSMISSION ELECTRON MICROSCOPY in which the object is examined directly by an extremely narrow electron beam scanning the specimen point-by-point and using the reactions of the electrons that are transmitted through the specimen to create the image. It should not be confused with SCANNING ELECTRON MICROSCOPY. .
0.38
201123
 
Interleukin-11 .
IL11 18793 .
Factor, Adipogenesis Inhibitory .
Inhibitory Factor, Adipogenesis .
Interleukin 11 .
Adipogenesis Inhibitory Factor .
IL-11 .
A lymphohematopoietic cytokine that plays a role in regulating the proliferation of ERYTHROID PRECURSOR CELLS. It induces maturation of MEGAKARYOCYTES which results in increased production of BLOOD PLATELETS. Interleukin-11 was also initially described as an inhibitor of ADIPOGENESIS of cultured preadipocytes. .
0.34
21181
 
Ophthalmoplegia, Chronic Progressive External .
Chronic Progressive External Ophthalmoplegia .
Graefe's Disease .
Ocular Myopathy of Von Graefe-Fuchs .
Ophthalmoplegia, Progressive External .
Progressive External Ophthalmoplegia .
Disease, Graefe .
Dystrophy, Ocular Muscular .
External Ophthalmoplegia, Progressive .
Muscular Dystrophies, Ocular .
Muscular Dystrophy, Ocular .
Myopathy, Mitochondrial Ocular .
Ocular Muscular Dystrophies .
Ocular Myopathy of Von Graefe Fuchs .
Ocular Myopathy, Mitochondrial .
CPEO 18745 .
Graefe Disease .
Mitochondrial Ocular Myopathy .
Ocular Muscular Dystrophy .
A mitochondrial myopathy characterized by slowly progressive paralysis of the levator palpebrae, orbicularis oculi, and extraocular muscles. Ragged-red fibers and atrophy are found on muscle biopsy. Familial and sporadic forms may occur. Disease onset is usually in the first or second decade of life, and the illness slowly progresses until usually all ocular motility is lost. (From Adams et al., Principles of Neurology, 6th ed, p1422) .
0.34
15476
 
Interactive Tutorial .
Interactive Media .
Video recordings or other files in which the progress of the instruction or content is determined by user response. .
0.34
00
 
Review .
Review Literature .
Review of Reported Cases .
Review, Academic .
Review, Multicase .
Review, Systematic .
Review, Academic .
Review, Multicase .
Review, Systematic .
Review, Tutorial .
Review of Reported Cases .
Review Literature .
Review [Publication Type] .
Review of Reported Cases [Publication Type] .
Review, Multicase [Publication Type] .
Review, Tutorial [Publication Type] .
Review Literature [Publication Type] .
Literature Review [Publication Type] .
Review, Academic [Publication Type] .
Review, Systematic [Publication Type] .
An article or book published after examination of published material on a subject. It may be comprehensive to various degrees and the time range of material scrutinized may be broad or narrow, but the reviews most often desired are reviews of the current literature. The textual material examined may be equally broad and can encompass, in medicine specifically, clinical material as well as experimental research or case reports. State-of-the-art reviews tend to address more current matters. A review of the literature must be differentiated from HISTORICAL ARTICLE on the same subject, but a review of historical literature is also within the scope of this publication type. .
0.33
00